APH Form 144 Filed for 199,848-Share Sale via Morgan Stanley on 08/22/2025

Rhea-AI Filing Summary

Amphenol Corporation (APH) Form 144 shows a proposed sale of 199,848 common shares through Morgan Stanley Smith Barney on the NYSE with an approximate sale date of 08/22/2025. The filing reports an aggregate market value of $22,069,674.29 and total shares outstanding of 1,220,921,111. The shares were recorded as acquired on 08/22/2025 by exercise of options under a registered plan and paid for in cash the same date. The filing notes "Nothing to Report" for securities sold in the past three months. Filer identity fields (CIK/CCC and contact details) are not populated in the provided content.

Positive

• Transaction documented as acquisition by exercise under a registered plan, indicating the shares derive from plan-issued options
• Broker and exchange specified (Morgan Stanley Smith Barney; NYSE), providing execution channel clarity
• No securities sold in the past three months reported for the person for whose account the securities are to be sold

Negative

• Proposed sale is sizable: 199,848 shares with an aggregate market value of $22,069,674.29, which is material in absolute terms
• Filer identity and contact fields are not populated in the provided content, reducing traceability
• Filing provides no name of the selling individual or explanation of intent beyond the required representation

Insights

Financial Analyst

TL;DR Insider proposes a single-day sale of 199,848 shares valued at ~$22.07M, acquired by option exercise the same day.

The transaction is clearly documented: acquisition by exercise under a registered plan on 08/22/2025 and a proposed sale through Morgan Stanley Smith Barney on the NYSE the same date. The size—199,848 shares with an aggregate market value of $22,069,674.29—is material in absolute dollar terms. The filing contains no information about the seller's identity or reasons for the sale, and reports no other sales in the prior three months. This is a routine disclosure of a proposed disposition following option exercise rather than new issuance or secondary offering documentation.

Corporate Governance Expert

TL;DR Documentation shows compliance with Rule 144 disclosure for a sizeable proposed sale after option exercise; limited contextual detail provided.

The form records the necessary transaction details: class, broker (Morgan Stanley Smith Barney), number of shares, market value, acquisition method, and payment. The absence of filer identification fields in the provided content reduces transparency for stakeholders reviewing insider activity. The filing’s statement that there were no securities sold in the past three months may be relevant for aggregation rules under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	199848	22069674.29	1220921111	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2025	Exercise of options under a registered plan	Issuer			199848	08/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Amphenol (APH) shares are proposed for sale in this Form 144?

The filing reports 199,848 common shares proposed for sale.

What is the aggregate market value of the proposed APH share sale?

The aggregate market value is reported as $22,069,674.29.

When were the shares acquired and how were they acquired?

The shares were acquired on 08/22/2025 by exercise of options under a registered plan and paid for in cash the same date.

Which broker and exchange are listed for the proposed sale of APH shares?

The broker is Morgan Stanley Smith Barney LLC, Executive Financial Services and the exchange is the NYSE.

Has the person sold any Amphenol securities in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.